Clinical, Cosmetic and Investigational Dermatology October 2019 Volume 2019:12 Pages 745—750. DOI https://doi.org/10.2147/CCID.S227232
- Vitamin D reduces hair loss
- which contains: The Hair Cycle and Vitamin D Receptor - 2011
- Hair loss strongly associated with poor vitamin D receptors– Dec 2016 authors are also in Egypt
- The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019
Items in both categories Autoimmune and Vitamin D Receptor are listed here:
- Autoimmune disease treated by Vitamin D, Zinc (and other activators of Vitamin D Receptor) – Oct 2019
- Vitamin D Receptor is associated in over 40 autoimmune studies
- Temporary hair loss (Telogen Effluvium) is 15X more likely if poor Vitamin D Receptor – Oct 2019
- Autoimmunity problems often associated with poor Vitamin D Receptors – March 2019
- Many autoimmune diseases associated with low vitamin D or poor Vit D genes – July 2019
- Adaptive and innate immune system, vitamin D genes, and Rheumatoid Arthritis – June 2019
- Resveratrol Role in Autoimmune Disease-A Mini-Review. – Dec 2016
- Immunological effects of vitamin D and their relations to autoimmunity – March 2019
- Resveratrol improves health (Vitamin D receptor, etc.)
- Vitiligo (spotty skin coloring) is 4 X more likely if poor Vitamin D Receptor – meta-analysis July 2018
- Vitamin D Receptor and autoimmune diseases – Jan 2017
- Inflammation and immune responses to Vitamin D (perhaps need to measure active vitamin D) – July 2017
- Many autoimmune diseases associated with latitude and vitamin D receptor – March 2016
- Vitamin D Receptor role in Autoimmune Diseases and or cancers – Nov 2013
- Endometriosis treated, and perhaps prevented, by vitamin D and Omega-3 - updated Fall 2019
Vitamin D Receptor table has many low cost ways to activate the VDR
Compensate for poor VDR by increasing one or more:
|1) Vitamin D supplement|
Sun, Ultraviolet -B
| Vitamin D in the blood |
and thus in the cells
|2) Magnesium||Vitamin D in the blood |
AND in the cells
|3) Omega-3||Vitamin D in the cells|
|4) Resveratrol||Vitamin D Receptor|
|5) Intense exercise||Vitamin D Receptor|
|6) Get prescription for VDR activator|
|Vitamin D Receptor|
|7) Quercetin (flavonoid)||Vitamin D Receptor|
|8) Zinc is in the VDR||Vitamin D Receptor|
|9) Boron||Vitamin D Receptor ?, |
|10) Essential oils e.g. ginger, curcumin||Vitamin D Receptor|
|11) Progesterone||Vitamin D Receptor|
|12) Infrequent high concentration Vitamin D|
Increases the concentration gradient
|Vitamin D in the cells|
|13) Sulfroaphone and perhaps sulfur||Vitamin D Receptor|
Note: If you are not feeling enough benefit from Vitamin D, you might try increasing VDR activation. You might feel the benefit within days of adding one or more of the above
Download the PDF from VitaminDWiki
Iman Seleit,1 Ola A Bakry,1 Eman Badr,2 Eman H Hassan1
- 1Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Menoufiya Governorate, Egypt;
- 2 Department of Medical Biochemistry, Faculty of Medicine, Menoufiya University, Menoufiya Governorate, Egypt
- Correspondence: Ola A Bakry: Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Shibeen El Koom, Menoufiya Governorate 32817, Egypt, Tel +201065190509, Email olabakry8 at gmail.com
Background: Telogen effluvium (TE) is a form of alopecia characterized by diffuse hair shedding. Vitamin D receptor (VDR) plays a role in hair cycle regulation as it is expressed in follicular keratinocytes and dermal papilla cells.
Purpose: To investigate the association between Cdx1 and Taq1 VDR gene polymorphisms and chronic TE.
Methods: Thirty female patients with chronic TE were selected and 30 healthy, age- and sex-matched volunteers were included as a control group. Detection of VDR gene polymorphisms Taq1 and Cdx1 was done by real-time polymerase chain reaction.
Results: Regarding Taq 1, CC genotype was present in 30% of cases versus 3.3% of controls. TC genotype was present in 33.3% of cases and 36.7% of controls. CC genotype was significantly associated with cases (P=0.01). It increases the risk of chronic TE by 14.7 folds. C allele was significantly associated with patient group (P=0.004).
It increases the risk of disease occurrence by 3.1 folds. Regarding Cdx1, AA genotype was present in 6.7% of cases versus 3.3% of controls. GA genotype was present in approximately 30% of cases and 6.7% of controls. GA genotype was significantly associated with cases (P=0.03). It increases the risk of chronic TE by 6.3 folds. A allele was significantly associated with patient group (P=0.007). It increases the risk of disease occurrence by 3.8 folds.
Limitations: The main limitation is the small number of cases due to the time and financial constraints. Only chronic TE was analyzed, therefore, other types should be investigated in the following studies.
Conclusion: After exposure to primary physical or mental stressor, hair follicles are stimulated to enter prematurely into telogen and shed out. In individuals with Taq1 and Cdx1 polymorphisms, the disease persists as a result of prevention of new anagen growth and inhibition of hair follicle stem cell proliferation.
- “Telogen effluvium is a form of temporary hair loss that usually happens after stress, a shock, or a traumatic event. It usually occurs on the top of the scalp”
- “Telogen effluvium (TE) is probably the second most common form of hair loss dermatologists see”